Natera (NTRA) news
Recent news
Natera, Inc.: Citigroup raises target price to $365 from $315
Citigroup analyst Patrick B. Donnelly has raised his price target for Natera (NASDAQ: NTRA) to $365 from $315, maintaining a Buy rating on the stock. The adjustment reflects the analyst’s continued confidence in the healthcare company’s growth potential, despite mixed signals from other analysts…
AInvest Wire · Aug 13, 2026Natera, Inc.: Stephens raises target price to $350 from $305
Stephens has raised its price target for Natera, Inc. (NASDAQ: NTRA) to $350 from $305, maintaining an Overweight rating on the stock. The adjustment follows the company’s strong financial performance and strategic progress in key areas of its business. Natera recently reported second-quarter 2026…
AInvest Wire · Aug 12, 2026Natera, Inc.: Piper Sandler raises target price to $363.5 from $249
AInvest Wire · Aug 12, 2026Natera, Inc.: Piper Sandler raises target price to $363.50 from $249
Piper Sandler analyst David Westenberg has raised his price target for Natera, Inc. (NASDAQ: NTRA) to $363.50 from $249, while maintaining a "Buy" rating on the stock. The adjustment reflects the firm’s confidence in expansion into Japan . Natera, a diagnostics company specializing in genetic…
AInvest Wire · Aug 12, 2026Guggenheim lifts Natera target to $360, from $290
AInvest Wire · Aug 12, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.